Today is Breast Reconstruction Awareness Day. With over 150,000 breast reconstruction procedures performed in the U.S. each year, why do one in three patients still face serious complications? At Elutia, we’re committed to changing that. #BRAday #BreastReconstruction
About us
At Elutia we are humanizing medicine so patients can thrive without compromise.
- Website
-
www.elutia.com
External link for Elutia
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Type
- Public Company
Employees at Elutia
-
Courtney Guyer
VP of Marketing and GM of Women's Health at Elutia (formerly known as Aziyo Biologics)
-
Jeff Hamet
-
Edward Rose
Medical Device Executive, Investor and Consultant | Start-up to Commercialization Expert
-
David Colpman
Independent Board Member and Business Development Consultant
Updates
-
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors. Read more: https://lnkd.in/gcY3f7CP
-
-
SimpliDerm is a pliable, easy-to-handle hydrated human acellular dermal matrix (hADM) designed specifically to promote rapid repopulation and revascularization for enhanced healing and integration. Learn more here: https://lnkd.in/g2VGFuNz
-
-
Today marks a major milestone. We officially closed the sale of our BioEnvelopes to Boston Scientific. Learn more about the sale and what is next for Elutia here: https://lnkd.in/e4F6FqBm
Boston Scientific has closed on an agreement with Elutia, Inc. to acquire the company’s bioenvelope assets, including the antibiotic-eluting EluPro™ BioEnvelope and the CanGaroo® BioEnvelope, designed to prevent certain post-operative complications for devices such as pacemakers and defibrillators. The addition of these devices to our portfolio will allow us to broaden their availability, providing a bioenvelope option for more physicians and their patients.
-
-
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation. Learn more: https://lnkd.in/g9EWjtDv
-
-
Last week, our team had the exciting opportunity to showcase our EluPro Bio-Envelope at the Vizient Innovative Technology Exchange! It was an incredible experience connecting with healthcare leaders, innovators, and decision-makers from across the country. A big thank you to everyone who stopped by our booth. #Vizientsummit #EluPro
-
-
Elutia BioEnvelopes are specifically engineered to support a natural biologic healing response versus a chronic-inflammatory response that can lead to scar formation. Learn more: https://lnkd.in/ga2E8cYb
-
-
Next week our team is headed to Las Vegas to showcase our EluPro BioEnvelope to healthcare leaders at the Vizient, Inc Innovative Technology Exchange. #Vizientsummit
-
-
Today, our CEO, Randall Mills spoke live at the H.C. Wainwright & Co., LLC 27th Annual Global Investment Conference. During the session, he offered valuable insight into the future direction of our business, highlighting how our focus will now shift to the development of NXT-41. Watch the webcast here: https://lnkd.in/dQini9Mn
-
-
📢 We are pleased to announce that Boston Scientific has entered into a definitive agreement with Elutia to acquire the EluPro™ BioEnvelope and the CanGaroo® Envelope. These products are designed to help prevent certain post-operative complications associated with implantable cardiac devices such as pacemakers and defibrillators. These advancements will further strengthen our ability to protect patients with these devices, and we look forward to equipping more physicians with technologies designed to improve clinical outcomes. https://lnkd.in/eeZ4y7sC
-